Application of robot-assisted minimally invasive esophagectomy for patients with esophageal cancer
- VernacularTitle:机器人辅助食管癌根治手术的应用
- Author:
ZHANG Hanlu
1
;
CHEN Longqi
1
;
GENG Yingcai
1
;
ZHENG Yu
1
;
WANG Zihao
1
;
WANG Fuqiang
1
;
LIN Yidan
1
;
HU Yang
1
;
YUAN Yong
1
;
WANG Wenping
1
;
WANG Yun
1
Author Information
- Publication Type:Journal Article
- Keywords: Esophageal neoplasms; da Vinci surgical system; robotic surgery
- From: Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2019;26(3):206-210
- CountryChina
- Language:Chinese
- Abstract: Objective To present the initial clinical experience of robot-assisted thoracoscopic esophagectomy for patients with esophageal cancer and to analyze the short-term outcomes of these patients. Methods Between February 2016 and December 2017, 148 patients with esophageal carcinoma underwent robotic esophagectomy and two-fields lymph node dissection. There were 126 males and 22 females at average age of 62.0±8.0 years. Demographic data, intraoperative characteristics and short-term surgical outcomes were collected and analyzed. Results 106 patients underwent McKeown esophagectomy and 42 patients underwent Ivor-Lewis esophagectomy. The mean operation time was 336.0±76.0 min, the mean intraoperative blood loss was 130.0±89.0 ml, the mean number of lymph nodes removed was 21.0±8.0 and the mean length of postoperative hospital-stay was 12.0±7.2 days. Postoperative complications included anastomotic fistula (n=8, 5.4%), pulmonary infection (n=13, 8.7%), hoarseness (n=23, 15.5%), tracheoesophageal fistula (n=1, 0.7%), chylothorax (n=4, 2.7%) and incision infection (n=2, 1.4%). There was no intra-operational massive hemorrhage or in-hospital mortality. Conclusion Both robot-assisted McKeown and Ivor-Lewis esophagectomy are safe and feasible with good early outcomes.
